Literature DB >> 22342542

Synthesis of D-ring-substituted (5'R)- and (5'S)-17β-pyrazolinylandrostene epimers and comparison of their potential anticancer activities.

Zoltán Iványi1, Nikoletta Szabó, Judit Huber, János Wölfling, István Zupkó, Mihály Szécsi, Tibor Wittmann, Gyula Schneider.   

Abstract

Various steroidal benzylidenes were synthetized from pregnenolone with benzaldehyde and p-substituted benzaldehydes. The resulting 17β-chalconyl derivatives of pregnenolone were reacted with hydrazine hydrate in acetic acid solution. Regardless of the starting material, the ring-closure reaction afforded (in contrast with the literature data) a mixture of two steroidal pyrazoline epimers. The epimers were critical isomer pairs, which could be separated only in their acetylated form; their structures were investigated by NMR techniques. The in vitro inhibition of rat testicular C(17,20)-lyase activity and the antiproliferative effects on four human cancer cell lines were measured, and the results obtained from the two epimer series were compared. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342542     DOI: 10.1016/j.steroids.2012.02.001

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  8 in total

1.  Lewis acid-induced intramolecular access to novel steroidal ring D-condensed arylpyrazolines exerting in vitro cell-growth-inhibitory effects.

Authors:  Gergő Mótyán; István Zupkó; Renáta Minorics; Gyula Schneider; János Wölfling; Éva Frank
Journal:  Mol Divers       Date:  2015-04-18       Impact factor: 2.943

2.  Synthesis, characterization and biological evaluation of some novel P-heterocyclic androst-4-ene derivatives.

Authors:  Natalija M Krstić; Vladimir D Pavlović; Irena T Novaković; Ivana Z Matić; Dušan M Sladić
Journal:  Mol Divers       Date:  2013-06-09       Impact factor: 2.943

3.  Synthesis of novel, DNA binding heterocyclic dehydroabietylamine derivatives as potential antiproliferative and apoptosis-inducing agents.

Authors:  Fengyi Zhao; Xu Sun; Wen Lu; Li Xu; Jiuzhou Shi; Shilong Yang; Mengyi Zhou; Fan Su; Feng Lin; Fuliang Cao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

4.  OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression.

Authors:  Mirco Masi; Enrico Garattini; Marco Bolis; Daniele Di Marino; Luisa Maraccani; Elena Morelli; Ambra A Grolla; Francesca Fagiani; Emanuela Corsini; Cristina Travelli; Stefano Govoni; Marco Racchi; Erica Buoso
Journal:  Oncogenesis       Date:  2020-12-11       Impact factor: 7.485

5.  Reaction of 7α-bromo-6-nitrocholest-5-enes with hydrazine: Formation of steroidal pyrazolines and molecular docking against SARS-CoV-2 omicron protease.

Authors:  Avadhesh Kumar; Mehtab Parveen; Mahboob Alam
Journal:  Steroids       Date:  2022-10-05       Impact factor: 2.760

Review 6.  Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.

Authors:  Dimitris Matiadis; Marina Sagnou
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

7.  Antiproliferative Properties of Newly Synthesized 19-Nortestosterone Analogs Without Substantial Androgenic Activity.

Authors:  András Gyovai; Renáta Minorics; Anita Kiss; Erzsébet Mernyák; Gyula Schneider; András Szekeres; Erika Kerekes; Imre Ocsovszki; István Zupkó
Journal:  Front Pharmacol       Date:  2018-07-27       Impact factor: 5.810

8.  Anti-Cancer Activity of Novel Dihydrotestosterone-Derived Ring A-Condensed Pyrazoles on Androgen Non-Responsive Prostate Cancer Cell Lines.

Authors:  Gergő Mótyán; Mohana Krishna Gopisetty; Réka Eleonóra Kiss-Faludy; Ágnes Kulmány; István Zupkó; Éva Frank; Mónika Kiricsi
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.